Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Weighted Average) (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Shares Outstanding (Weighted Average) data on record, last reported at $227.4 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 0.56% year-over-year to $227.4 million; the TTM value through Sep 2025 reached $227.4 million, up 0.56%, while the annual FY2024 figure was $226.2 million, 48.23% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $227.4 million in Q3 2025 per GOSS's latest filing, roughly flat from $227.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $227.4 million in Q3 2025 and bottomed at $75.9 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $162.7 million, with a median of $192.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): skyrocketed 137.94% in 2024, then grew 0.37% in 2025.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $84.6 million in 2022, then soared by 80.46% to $152.6 million in 2023, then soared by 48.23% to $226.2 million in 2024, then rose by 0.5% to $227.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $227.4 million in Q3 2025, $227.0 million in Q2 2025, and $226.8 million in Q1 2025.